KTWIY yields 1.46% · PFE yields 6.13%● Live data
📍 KTWIY pulled ahead of the other in Year 1
Combined, KTWIY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KTWIY + PFE for your $10,000?
Kurita Water Industries Ltd. provides various water treatment solutions in Japan, Asia, North America, South America, Europe, the Middle East, Africa, and internationally. The Water Treatment Chemicals segment offers boiler water treatment chemicals, cooling water treatment chemicals, wastewater treatment chemicals, process treatment chemicals, reverse osmosis membrane water treatment chemicals, automobile paint booth chemicals, biomass generation related chemicals, civil engineering and construction related chemicals, marine vessel related water treatment chemicals, chemical dosing systems/chemical dosing control systems, and packaged contract services. The Water Treatment Facilities segment offers water treatment equipment and facilities; ultrapure water production systems, tool cleaning, plant cleaning, and soil and groundwater contamination remediation services; and swimming pool related equipment services. This segment also provides ultrapure water production systems, wastewater reclamation systems, and wastewater treatment systems and equipment. It also offers soil and groundwater contamination remediation, plant facilities cleaning, and precision tool cleaning services, as well as water treatment equipment for professional use, products for general household's, and swimming pool-related equipment. The company was incorporated in 1949 and is headquartered in Tokyo, Japan.
Full KTWIY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.